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Emergent infrahepatic vena cava stenting for
life-threatening perforation
Geert de Naeyer, MD, and Ivan Degrieck, MD, Aalst, Belgium
During a lumbar vertebral fusion, a box cage perforated the inferior vena cava wall and migrated toward the right
atrium. This case report describes the use of a Talent endoluminal stent-graft to control the subsequent life-
threatening bleeding and to prevent further migration of the box cage into the right atrium, with the risk of
pulmonary embolization. It shows that the use of minimal invasive endovascular stent-grafts to control for massive
vena cava bleeding might be a less invasive procedure and, in similar cases, could be a life-saving alternative to open
surgery. ( J Vasc Surg 2005;41:552-4.)Massive bleeding from inferior vena cava (IVC) lesions
is a surgical emergency that usually requires invasive open
surgical repair.1-3 In this case report, we describe the use of
a Talent endoluminal stent-graft (Medtronic Inc, Minne-
apolis, Minn) to control massive life-threatening bleeding
after perforation of the infrahepatic vena cava by a box cage
used for lumbar vertebral fusion. This case report shows
that the use of minimal invasive endovascular stent-grafts in
vena cava bleeding might be a less invasive procedure and
could be a life-saving alternative to open surgery.
CASE REPORT
During a posterior lumbar interbody fusion at the L3-4 level
in a 51-year-old woman, 2 box cages (carbon cylindrical cages with
a diameter of 5 mm and filled with bone grafts) were manually
screwed into the intervertebral space at the L3-4 level. Suddenly
significant venous bleeding existed. A fluoroscopic control with
injection of contrast dye via the wound was performed. This
showed opacification of the IVC and perforation of the left-sided
box cage through the IVC wall, with subsequent migration ap-
proximately 2 cm downstream in the IVC. The perforation oc-
curred because of a malpositioning of the right-sided box cage,
which pushed the left side through the IVC wall. Because of the
major bleeding, with cardiovascular instability, the decision was
made to perform an emergent endovascular stenting with a Talent
thoracic aortic stent-graft (44 mm). Two Talent balloons were
inserted into the IVC through the intervertebral space by using the
existing surgical incision. The first balloon was directed down-
stream and inflated subocclusively to prevent migration of the box
cage but to allow some residual blood flow toward the right
atrium. The second balloon was directed upstream and inflated to
reduce the blood flow from the lower body and to achieve accept-
able hemostasis. The wound was closed with the 2 balloons in situ
(Figs 1 and 2), and the patient was repositioned into the dorsal
decubitus position and transferred to the cardiovascular surgery
operating room.
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552After right common femoral vein puncture, a Talent
44-mm thoracic endoprosthesis was inserted alongside the sub-
totally inflated balloons. After the free bars of the stent-graft
were located proximal from the intracaval box cage and the
stent-graft covering the IVC tear, it was subtotally expanded.
Afterward the proximal and distal balloons (running outside the
stent-graft) were deflated and retracted. The dilation of the
endoprosthesis was completed, and it was positioned between
the iliac bifurcation and the renal veins, with the box cage fixed
between the endoprosthesis and the IVC wall as shown in Fig 3.
A perfect hemostasis was achieved, with no endoleak on control
venography.
The patient recovered well from this procedure. For preven-
tion of thrombotic complications, oral anticoagulation therapy
with coumarines was started on the second postoperative day. The
only remarkable postoperative finding, on a computed tomo-
graphic scan at 18 months, was the presence of thrombotic mate-
rial against the IVC wall, as shown in Fig 3.
DISCUSSION
Life-threatening bleeding from the IVC can occur from
blunt abdominal trauma, penetrating injuries, and iatro-
genic trauma, especially during abdominal or retroperito-
neal operations.4 Until recently, repair of hemodynamically
important vena cava tears required open surgical techniques
with invasive surgical handling. In the literature, mortality
rates for emergent open vena cava repair after traumatic
laceration vary from 38.6% to 80%.1-3,5 Mortality rates after
iatrogenic vena cava lesions might be lower, but data are
lacking on this subject.
Recently, Wang et al6 reported on another life-threatening
bleeding episode from an IVC tear during spinal fusion
surgery; this was disclosed via emergent exploratory lapa-
rotomy. Unfortunately, their patient died as a result of
multiple organ failure.
Today, routine and successful use of stent-grafts for
arterial pathology has made surgeons handier with the
material and techniques of endovascular procedures.7 Even
so, endograft stenting for venous pathology remains lim-
ited for treating inferior and superior vena cava stenosis and
obstruction.8,9
Still, for the repair of life-threatening vena cava inferior
bleeding, we have found only 2 case reports. Erzurum
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(Medtronic Inc, Minneapolis, Minn) to control life-threat-
ening bleeding from lesions in the retrohepatic IVC during
an attempted resection of a retroperitoneal leiomyosar-
coma. Watarida et al11 reported the use of a fenestrated
stent-graft for a traumatic juxtahepatic IVC injury. How-
ever, the use of balloon catheters introduced via the tear to
control major bleeding from the IVCwas recommended by
Ravikumar and Stahl12 in the 1980s. The presence of the
bone cage in the vena cava with the risk of further migra-
tion, the existing intervertebral access, and the hemody-
Fig 1. Fluoroscopic view of the inferior vena cava with a down-
and upstream balloon in order to achieve good hemostasis.
Fig 2. Schematic representation of the patient in the knee-elbow
position with a down- and upstream balloon in the IVC in order to
prevent migration and to achieve a good hemostasis, respectively.namic instability made us decide to perform this procedure.However, there are some limitations. This procedure of
endovascular stent-grafting needs visualization by venogra-
phy. Most patients with major IVC lesions present with
hemodynamic instability that necessitates urgent laparot-
omy without time for venography, which is needed for the
endovascular technique. Despite the oral coumarine ther-
apy, which should be continued indefinitely, the vena cava
wall thrombi can be a risk of progressive IVC narrowing
and pulmonary embolization. There is also no information
regarding use of arterial endograft material for venous
endovascular procedures. Thus, a risk of perforation of the
vena cava wall with subsequent bleeding should be consid-
ered.13 Close follow-up of these patients is strongly ad-
vised.
CONCLUSION
Although lacerations or perforations of the IVC might
be rare, they are extremely serious and possibly lethal
problems because of their difficulty in diagnosis, technical
problems with repair, and massive bleeding. Although fur-
ther experience with and follow-up of such cases is needed
to determine the pitfalls and tricks of this technique, we
believe that endovascular stent-graft placement for IVC
injury is safe, effective, and the procedure of choice in
experienced and organized centers.
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